Drugs & Targets Prix Galien Foundation announces “Discovery of the Decade” nominees September 30, 2016Vol.42 No.36
Drugs & Targets Genomics England Partners with GenomOncology on 100,000 Genomes Project September 30, 2016Vol.42 No.36
Drugs & Targets Boehringer Ingelheim and ViraTherapeutics to collaborate on oncolytic virus therapy platform September 30, 2016Vol.42 No.36
Drugs & Targets Janssen submits supplemental FDA New Drug Application for ibrutinib September 30, 2016Vol.42 No.36
Drugs & Targets Dignity Health, Catholic Health Initiatives Launch Precision Medicine Alliance September 23, 2016Vol.42 No.35
Drugs & Targets ORIEN and HudsonAlpha announce new research collaboration September 23, 2016Vol.42 No.35
Drugs & Targets St. Jude Children’s Research Hospital and Wellcome Trust Sanger Institute agree to exchange cancer mutation data September 23, 2016Vol.42 No.35
Drugs & Targets Golden Meditech and MD Anderson announce creation of Cellenkos Inc. September 23, 2016Vol.42 No.35
Drugs & Targets EMA recommends conditional marketing authorization for olaratumab September 23, 2016Vol.42 No.35
Drugs & Targets Novartis, MEI Pharma. Receive Breakthrough Therapy Designations September 22, 2016Vol.39 No.08
